GSTM1 and colorectal cancer: In the present study, we found that using both FIT with a f-Hb threshold of 10 μg/g and the presence or absence of anaemia increased sensitivity for colorectal cancer from 91.80% to 98.28% and NPV from 99.87% to 99.96%.